Authors’ reply to letters to the editor “model-based simulation to support the extended dosing regimens of atezolizumab”

Research output: Contribution to journal › Letter › peer-review

Original language	English
Journal	European Journal of Clinical Pharmacology
DOIs	https://doi.org/10.1007/s00228-020-03055-z
Publication status	Accepted/In press - 2020

All Science Journal Classification (ASJC) codes

@article{c74a077a96b541439a74e2829f4eb1ed,

title = "Authors{\textquoteright} reply to letters to the editor “model-based simulation to support the extended dosing regimens of atezolizumab”",

author = "Chou, {Chen Hsi} and Hsu, {Li Feng}",

year = "2020",

doi = "10.1007/s00228-020-03055-z",

language = "English",

journal = "European Journal of Clinical Pharmacology",

issn = "0031-6970",

publisher = "Springer Verlag",

}

TY - JOUR

T1 - Authors’ reply to letters to the editor “model-based simulation to support the extended dosing regimens of atezolizumab”

AU - Chou, Chen Hsi

AU - Hsu, Li Feng

PY - 2020

Y1 - 2020

UR - http://www.scopus.com/inward/record.url?scp=85096593269&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85096593269&partnerID=8YFLogxK

U2 - 10.1007/s00228-020-03055-z

DO - 10.1007/s00228-020-03055-z

M3 - Letter

AN - SCOPUS:85096593269

JO - European Journal of Clinical Pharmacology

JF - European Journal of Clinical Pharmacology

SN - 0031-6970

ER -